Tabernacle Havana Seed CT No. 142

Cigar News: Foundation Cigars Starts Shipping Tabernacle Havana Seed CT #142

Through Email Blasts and Social Media Posts, Foundation Cigar Co. has announced they have begun shipping the new Tabernacle Havana Seed CT #142. The cigar was announced at this years IPCPR and the is of the most anticipated cigars for 2018. In the announcement the company quotes the most recent Cigar Insider article:  “Blending The[…]

The Tabernacle Havana Seed CT. No. 142

Cigar Review: Foundation Cigars The Tabernacle Havana Seed CT No. 142 – Rated 97

It has been three months since we presented Nick Melillo the award for the Stogie Press #1 Boutique Cigar of the 2017. The award for the excellent craftsmanship, and superb blend, of the Wise Man Maduro. Those that have enjoyed that cigar probably don’t disagree with our assessment. Now, here we are, 3 months later,[…]

The Tabernacle Lancero

Foundation Cigar Co. The Tabernacle Lancero Cigar Review

Back in August of 2016, I had the pleasure of reviewing the The Tabernacle Toro cigar which was one of the fantastic blends Nick Melillo introduced at the 2016 IPCPR.  So when my good friend and Stogie Press associate, Alton Otto, gifted me some Lanceros of The Tabernacle. I have to say I was grateful for[…]

A. Flores 1975 Gran Reserva Desflorada

2016 Top Connecticut Cigars –

FOR IMMEDIATE RELEASE January 15, 2017 Once again, Stogie Press brings you our pick of the top Connecticut cigars for the past year. We created this category because Connecticut wrapped cigars don’t always get the recognition they deserve. Although many think these blonde beauties are mild compared to their darker brethren, that is not always the[…]

Foundation Cigar Charter Oak

Foundation Cigars Charter Oak – Rough Cut Cigar Review

I have always said, what this country needs is a good $5.00 premium cigar. While the industry has largely been marketing $8.00 to $12.00 cigars in recent years, partly due, to the arbitrary $10.00 price point the FDA and the increase demand for tobacco. The FDA price point is now moot since they did not[…]